FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under
the Securities Exchange Act of 1934
For the
month of July,
2011 .
Commission File Number 0-16174
TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
(Translation of registrant’s name into English) |
5 Basel Street, P.O. Box 3190 |
Petach Tikva 49131 Israel |
(Address of principal executive offices) |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
|
Form 20-F X |
Form 40-F |
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(1):___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):___
-1-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
|
||||
(Registrant) |
|
||||
By: |
|
/s/ Eyal Desheh |
|||
Name: Eyal Desheh |
|||||
Title: Chief Financial Officer |
|||||
Date: |
July 27, 2011 |
|
|